跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MYLAN-DIVALPROEX - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MYLAN-DIVALPROEX
Authorized
STANDARD
MYLAN-DIVALPROEX
Mylan Pharmaceuticals ULC
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
77c115b05d30a43b
Company
Mylan Pharmaceuticals ULC
Type
Standard
Approval Details
Approval Id
77c115b05d30a43b
Drug Approval Canada Name
MYLAN-DIVALPROEX
Product Name
MYLAN-DIVALPROEX
Status
Marketed
Status Date
2017-05-21
Original Market Date
2017-05-21
Din
02458934
Drug Class
Human
Dosage Form
Tablet (Delayed-Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:12.92
Atc Original
N03AG01 VALPROIC ACID
Atc Name
n 03 ag 01
Aig Number
0112996001
Company Name
Mylan Pharmaceuticals ULC
Company Address
85 Advance Road, Etobicoke, Ontario, Canada, M8Z 2S6
Active Ingredients
VALPROIC ACID (DIVALPROEX SODIUM)
250 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
77c115b05d30a43b
Type
Standard
Back to Health Canada Approvals